The vaccine was custom-brewed for each patient to match their tumor. It teaches the patient’s immune system to watch out for ...
A first-of-its-kind cancer vaccine is significantly reducing the chances that melanoma patients’ tumors come back, according ...
When the news arrived in August that what could be the first personalized mRNA cancer vaccine had succeeded in a late-stage clinical trial in melanoma, oncologists and the public alike were ...
Moderna launched its coronavirus vaccine in early pandemic days and saw revenue and stock performance skyrocket. As demand ...
About 9% of adults hospitalized with RSV died in the hospital or within 30 days of discharge, according to preliminary data ...
New Scientist on MSN
Personalised cancer vaccine expected to be approved next year
A bespoke vaccine that is tailored to target an individual's unique skin cancer reduced rates of recurrence or death in a ...
CAMBRIDGE, MA / ACCESS Newswire / October 23, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced it was ranked as a top ...
An mRNA-based melanoma vaccine has been shown to reduce the risk of death or cancer coming back among patients by 42 percent. Auckland University Professor Helen Petousis-Harris says it's quite ...
A personalised mRNA cancer vaccine, used alongside an existing immunotherapy drug, has been linked to a 42 percent reduction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results